Table 4 Impact of the implantation technique in patients with diabetes
From: Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds
Diabetes | Implantation Technique | |||
|---|---|---|---|---|
No (63) | Yes (74) | p | HR 95% KI | |
all death | 4/63 6%) | 7/74 (9%) | 0.3415 | 0.56 0.17–1.84 |
CV death | 3/63 (5%) | 6/74 (8%) | 0.284 | 0.48 0.13–1.81 |
any MI | 10/63 (16%) | 5/74 (7%) | 0.1207 | 2.28 0.81–6.17 |
TV- MI | 9/63 (14%) | 1/74 (1%) | 0.006 | 10.27 1.64–19.80 |
TLR | 19/63 (30%) | 2/74 (3%) | 0.0001 | 10.79 22.49–13.97 |
TVR | 25/63 (40%) | 7/74 (9%) | 0.0001 | 4.41 1.94–7.86 |
ScR | 17/63 (27%) | 1/74 (1%) | 0.0001 | 18.54 2.61–16.80 |
ScT | 2/63 (3%) | 2/74 (3%) | 0.9722 | 1.03 0.14–7.45 |
DOCE | 22/63 (35%) | 8/74 (11%) | 0.0021 | 3.29 1.51–6.41 |